Protease inhibitors and non-nucleoside reverse transcriptase inhibitors have a comparable effect on the CD4 cell change after switching to tenofovir-based regimens

F. van Leth, J.M. Prins, J.M. Lange, S.E. Geerlings
Type
Journal article
Publication
AIDS
Humans HIV Infections Anti-HIV Agents HIV Protease Inhibitors Reverse Transcriptase Inhibitors HIV Infections/*drug therapy Anti-HIV Agents/*therapeutic use CD4 Lymphocyte Count CD4-Positive T-Lymphocytes Drug Therapy Combination Reverse Transcriptase Inhibitors/*therapeutic use Adenine Adenine/*analogs & derivatives/therapeutic use CD4-Positive T-Lymphocytes/*drug effects HIV Protease Inhibitors/therapeutic use Phosphonic Acids Phosphonic Acids/*therapeutic use